COMMUNIQUÉS West-GlobeNewswire

Zealand Pharma files registration statement for proposed initial public offering of ADSs in the U.S.
06/07/2017
Company announcement - No. 25/2017 Zealand Pharma files registration statement for proposed initial public offering of ADSs in the U.S. Zealand has today filed a registration statement for the proposed initial public [...]
VALNEVA : Déclaration d'actions et de droits de vote - Juin 2017
06/07/2017
VALNEVA Déclaration d'actions et de droits de vote - JUIN 2017 Dénomination sociale : VALNEVA Adresse du siège social : World Trade Center Lyon, Tour Oxygène, 10-12 Boulevard Marius Vivier Merle, 69003 Lyon Marché [...]
VALNEVA : Bilan semestriel du contrat de liquidité
06/07/2017
Paris, le 6 juillet 2017 Bilan semestriel du contrat de liquidité VALNEVA contracté avec NATIXIS Au titre du contrat de liquidité confié à NATIXIS portant sur les actions de la société VALNEVA, à la date du 30 juin 2017 [...]
Weifa ASA: Invitation to presentation of Weifa's Q2 2017 results, Thursday 13 July 2017
06/07/2017
Oslo, 6 July 2017 Weifa ASA (OSE: WEIFA), Norway's leading consumer health company, will release its second quarter and first half 2017 results on Thursday 13 July 2017. The results will be presented by Weifa's CEO [...]
CrownBio Demonstrates Scientific Advancements in Metabolic Disease with a validated and improved translatable model for obesity and Type 2 Diabetes drug discovery
06/07/2017
SANTA CLARA, Calif., July 06, 2017 (GLOBE NEWSWIRE) -- Crown Bioscience , a wholly-owned subsidiary of Crown Bioscience International (TWSE: ticker 6554) and a global drug discovery and development services company [...]
ProMIS(TM) Neurosciences' Sponsored Research Agreement with University of British Columbia Receives Matching Grant from Canadian Institutes of Health Research
06/07/2017
TORONTO and CAMBRIDGE, Mass., July 06, 2017 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc., a biotechnology company focused on the discovery and development of precision treatments for neurodegenerative diseases, today [...]
Shire submits investigational New Drug Application to FDA for Gene Therapy candidate SHP654 for treatment of Hemophilia A
06/07/2017
Shire submits investigational New Drug Application to FDA for Gene Therapy candidate SHP654 for treatment of Hemophilia A SHP654 aims to deliver sustained protection against bleeds for patients with hemophilia A [...]
Targovax ASA: Registration of share capital increase following the private placement
06/07/2017
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY IN OR INTO THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE [...]
Novartis receives approval in the EU for Cosentyx label update, includes long term superiority data versus Stelara in psoriasis
06/07/2017
Label update includes 52 week data from CLEAR study demonstrating long-term superiority of Cosentyx ® versus Stelara ® in psoriasis [1],[2] Update also includes use of Cosentyx in moderate-to-severe scalp psoriasis[1 [...]
Shire plc : Additional Listing
06/07/2017
Additional Listing July 6, 2017 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company") hereby notifies the market that an application has been made to the London Stock Exchange and the UK Listing Authority for a total of [...]
MITHRA STRENGTHENS E4 PATENT POSITION IN AUSTRALIAN MARKET
06/07/2017
PRESS RELEASE MITHRA StRENGTHENS E4 PATENT POSITION in australiaN MARKET Patents granted for Estetrol (E4) synthesis protect manufacturing process until 2032 Certificate of grant covers E4's use alone as an emergency [...]
PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")
06/07/2017
pdf version of the press release This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients. The issuer of this announcement warrants that they are solely [...]
MDxHealth Launches AssureMDx for Bladder Cancer Liquid Biopsy Test
06/07/2017
Study reports test could reduce invasive diagnostic procedures by 77% NEWS RELEASE / REGULATED INFORMATION / INSIDE INFORMATION IRVINE, CA, and HERSTAL, BELGIUM - 07:00 CEST, July 6, 2017 - MDxHealth SA (Euronext: MDXH. [...]
MDxHealth lance AssureMDx, un test de biopsie liquide pour la détection du cancer de la vessie
06/07/2017
Une étude révèle que le test pourrait réduire les techniques invasives de diagnostic de 77 % COMMUNIQUE DE PRESSE / INFORMATION REGLEMENTAIRE / INFORMATION PRIVILEGIEE IRVINE, CA, and HERSTAL, BELGIQUE - 07:00 CEST, 6 [...]
Le candidat-médicament QRX-411 de ProQR pour le syndrome d'Usher obtient la désignation d'Orphan Drug (médicament orphelin) de la FDA et de l'EMA
06/07/2017
Principaux résultats Le QRX-411 de ProQR obtient la désignation Orphan Drug (médicament orphelin) par la FDA et l'EMA pour le traitement de la rétinite pigmentaire, y compris le syndrome d'Usher, le sous-type ciblé par [...]
Taconic Biosciences and Pharmatest Services Ltd. Create First Human Immune System Model for Bone Metastasis
05/07/2017
Researchers hopeful this new model will address incurable and painful disease HUDSON, N.Y., July 05, 2017 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in genetically engineered mouse models and associated [...]
ETC's Sterilization Systems Group Awarded Eight Contracts
05/07/2017
For Immediate Release SOUTHAMPTON, PA, USA , July 5, 2017 - Environmental Tectonics Corporation's (OTC Pink: ETCC) ("ETC" or the "Company") Sterilization Systems Group ("SSG") today announced that calendar year to date [...]
Bilan semestriel du contrat de liquidité DBV Technologies contractés avec Natixis
05/07/2017
Informations Réglementées Montrouge, France, le 05 juillet 2017, 22h30 CEST Bilan semestriel du contrat de liquidité DBV Technologies contractés avec Natixis Montrouge, France le 5 juillet 2017 - Au titre du contrat de [...]
Half-Year Report on the DBV Technologies Liquidity Contract with Natixis
05/07/2017
AMF REGULATED INFORMATION Montrouge, France, July 5, 2017 Half-Year Report on the DBV Technologies Liquidity Contract with Natixis Under the liquidity contract between DBV TECHNOLOGIES and NATIXIS, the following assets [...]

Pages